Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 16;14(10):1312.
doi: 10.3390/life14101312.

Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma

Sanika Suvarnapathaki  1 , Antolin Serrano-Farias  1 , Jonathan C Dudley  1   2 , Chetan Bettegowda  1 , Jordina Rincon-Torroella  1
Affiliations
Review

Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma

Sanika Suvarnapathaki et al. Life (Basel). .

Abstract

Using microRNAs (miRNAs) as potential circulating biomarkers in diagnosing and treating glioblastoma (GBM) has garnered a lot of scientific and clinical impetus in the past decade. As an aggressive primary brain tumor, GBM poses challenges in early detection and effective treatment with significant current diagnostic constraints and limited therapeutic strategies. MiRNA dysregulation is present in GBM. The intricate involvement of miRNAs in altering cell proliferation, invasion, and immune escape makes them prospective candidates for identifying and monitoring GBM diagnosis and response to treatment. These miRNAs could play a dual role, acting as both potential diagnostic markers and targets for therapy. By modulating the activity of various oncogenic and tumor-suppressive proteins, miRNAs create opportunities for precision medicine and targeted therapies in GBM. This review centers on the critical role and function of circulating miRNA biomarkers in GBM diagnosis and treatment. It highlights their significance in providing insights into disease progression, aiding in early diagnosis, and potential use as targets for novel therapeutic interventions. Ultimately, the study of miRNA would contribute to improving patient outcomes in the challenging landscape of GBM management.

Keywords: circulating biomarkers; early detection; glioblastoma; liquid biopsy; miRNA; precision medicine.

PubMed Disclaimer

Conflict of interest statement

C.B. is a consultant for Depuy-Synthes, Bionaut Labs, Haystack Oncology, and Privo Technologies. C.B. is a co-founder of OrisDx and Belay Diagnostics.

Figures

Figure 1
Figure 1
Liquid biopsies present a new diagnostic paradigm enabling less-invasive detection of circulating tumor biomarkers in blood and CSF of patients.
Figure 2
Figure 2
Key roles played by miRNAs in GBM tumor progression, metastasis, and treatment resistance are summarized here, making these miRNAs valuable diagnostic and therapeutic biomarkers for GBM patients.
See this image and copyright information in PMC

References

    1. Ostrom Q.T., Price M., Neff C., Cioffi G., Waite K.A., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020. Neuro-Oncol. 2023;25((Suppl. S4)):iv1–iv99. doi: 10.1093/neuonc/noad149. - DOI - PMC - PubMed
    1. Schaff L.R., Mellinghoff I.K. A Review of Glioblastoma and Other Primary Brain Malignancies—Reply. JAMA. 2023;330:189–190. doi: 10.1001/jama.2023.8590. - DOI - PubMed
    1. Elshafeey N., Kotrotsou A., Hassan A., Elshafei N., Hassan I., Ahmed S., Abrol S., Agarwal A., El Salek K., Bergamaschi S. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat. Commun. 2019;10:3170. doi: 10.1038/s41467-019-11007-0. - DOI - PMC - PubMed
    1. Galldiks N., Kaufmann T.J., Vollmuth P., Lohmann P., Smits M., Veronesi M.C., Langen K.-J., Rudà R., Albert N.L., Hattingen E., et al. Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group. Neuro-Oncol. 2024;26:1181–1194. doi: 10.1093/neuonc/noae049. - DOI - PMC - PubMed
    1. Schaff L.R., Mellinghoff I.K. Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. JAMA. 2023;329:574–587. doi: 10.1001/jama.2023.0023. - DOI - PMC - PubMed

LinkOut - more resources